ABSTRACT
Overview Currently, multiple vaccines for coronavirus disease 2019 (COVID-19) are in clinical trials. In Oct-Nov 2020, 1078 individuals in West Bengal surveyed to evaluate possible acceptance rates, affordability and factors affecting the acceptance of a vaccine for COVID-19.
Result 77.27 percent of respondents reported that they would be very or very likely to take a vaccine for COVID-19, 5.3 percent don’t want to take vaccine and 12.24 don’t know about their decision. In that 58 percent respondents want to take Indian Vaccine; 19 percent respondents want to take foreign vaccine. Other respondents can take any vaccine. The affordability, 40 percent respondents want a vaccine bellow 500 INR, 25 percent respondents want a vaccine of 500-1000 INR. 11 percent respondents want vaccine of over 1000 INR.
Method of Study The google form is prepared with the questions on acceptance and affordability of vaccines. The form is circulated digitally among the people and then we have collected the data in excel. Based on the result we have prepared our statistical graphs.
Conclusion Majority of Responders want a COVID 19 vaccine. Majority responders want Indian COVID19 Vaccine. Majority responders want a vaccine in a cost of below 500 INR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding is attached to the study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethical approval of this study is achieved from Ethical team of St. Xavier's College (Autonomous) Kolkata, University of Calcutta and the Responders consent also taken in the survey form. This study doesn't have any funding.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵a First Authors
G Research Guide
Funding: NIL
Conflict of Interest: No
Consent of the respondents: Taken
Data Availability
Data are collected from the survey among the 1078 people of west bengal
